Clinical Trial Detail

Contact

Missing content? – Request curation!

Request curation for specific Genes, variants, or PubMed publications.

Have questions, comments or suggestions? - Let us know!

Email us at : ckbsupport@jax.org

NCT ID NCT02098343
Title p53 Suppressor Activation in Recurrent High Grade Serous Ovarian Cancer, a Phase Ib/II Study of Systemic Carboplatin Combination Chemotherapy With or Without APR-246
Recruitment Completed
Gender female
Phase Phase Ib/II
Variant Requirements Yes
Sponsors Aprea Therapeutics AB
Indications

ovarian carcinoma

Therapies

Carboplatin + Doxorubicin

APR-246 + Carboplatin + Doxorubicin

Age Groups: adult | senior
Covered Countries USA | FRA | ESP | DEU | BEL

Additional content available in CKB BOOST